BMO Capital Initiates Coverage on Solventum Corporation (SOLV) with Market Perform

Market Context

Solventum Corporation operates in the Healthcare sector. The stock currently trades at $75.96 with a market capitalization of $14.4B. The stock has gained 14.6% over the past 52 weeks.

Analyst coverage from BMO Capital provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Solventum Corporation.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Solventum Corporation

Among the 10 most recent ratings: 6 Buy, 3 Hold, 1 Sell.

Date	Firm	Rating	Price Target
Jul 09, 2026	BMO Capital	Market Perform	N/A
May 15, 2026	Wedbush	Outperform	N/A
May 06, 2026	Stifel	Buy	N/A
May 06, 2026	UBS	Neutral	N/A
May 06, 2026	Keybanc	Overweight	N/A

Related Tools: Analyst Ratings Dashboard | View SOLV Stock Page